X4 Pharmaceuticals, Inc.
XFORNASDAQHealthcare● Active
$3.88
+$0.17(+4.58%)
Market Cap$365960420
P/E Ratio—
52W High$4.83
52W Low$1.35
X4 Pharmaceuticals, Inc. (XFOR) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · XFOR · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $253.00M | $102.06M | $114.22M | $121.72M | $81.79M |
| Net Receivables | $0.57M | $1.71M | $0.56M | $1.15M | $0.75M |
| Inventory | $4.48M | $2.82M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $261.58M | $112.17M | $122.08M | $128.68M | $87.88M |
| PP&E Net | $1.59M | $4.84M | $6.39M | $8.33M | $10.22M |
| Goodwill | $17.35M | $17.35M | $17.35M | $17.35M | $17.35M |
| Intangible Assets | $9.25M | $10.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $290.46M | $146.45M | $147.26M | $155.59M | $117.18M |
| Liabilities | |||||
| Short-Term Debt | $0.00M | $0.00M | $0.00M | $1.31M | $1.87M |
| Accounts Payable | $5.70M | $8.62M | $8.95M | $7.78M | $4.28M |
| Total Current Liabilities | $25.76M | $32.88M | $22.86M | $22.32M | $14.02M |
| Long-Term Debt | $76.29M | $75.42M | $54.57M | $32.30M | $33.14M |
| Total Liabilities | $104.17M | $124.30M | $96.16M | $81.53M | $52.76M |
| Stockholders Equity | |||||
| Retained Earnings | ($594.55M) | ($515.36M) | ($477.90M) | ($376.74M) | ($282.87M) |
| Total Stockholders Equity | $186.29M | $22.15M | $51.10M | $74.05M | $64.41M |
| Total Liab & Equity(computed) | $290.46M | $146.45M | $147.26M | $155.59M | $117.18M |
| Debt Summary | |||||
| Total Debt | $77.28M | $78.09M | $58.28M | $38.42M | $39.78M |
| Net Debt | ($139.76M) | $22.39M | ($40.94M) | ($83.30M) | ($42.00M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more X4 Pharmaceuticals, Inc. data
About X4 Pharmaceuticals, Inc. (XFOR) Balance Sheet
X4 Pharmaceuticals, Inc. (XFOR) balance sheet shows total assets of $0.29B with cash of $0.25B. Total liabilities are $0.10B, total debt $0.08B, and stockholders equity $0.19B.
Frequently asked questions
XFOR · 4 questionsX4 Pharmaceuticals, Inc. has total debt of $0.08B with net debt of ($0.14B).
XFOR total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10